Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 6 analysts offering 12 month price targets for Tonghua Dongbao Pharmaceutical Co Ltd have a median target of 12.71, with a high estimate of 14.08 and a low estimate of 9.00. The median estimate represents a 79.77% increase from the last price of 7.07.
High | 99.2% | 14.08 |
Med | 79.8% | 12.71 |
Low | 27.3% | 9.00 |
Dividends in CNY
Div growth (TTM) | -50.00% |
---|
More ▼
Earnings history & estimates in CNY
The next earnings announcement is expected on Jan 31, 2025.
Average growth rate | +9.88% |
Average growth rate | +13.06% |
More ▼
Revenue history & estimates in CNY
Average growth rate | -18.53% |
Average growth rate | +3.21% |
More ▼